(Q33867997)

29 July 2017

1 reference

title

Peroxisome proliferator-activated receptors: insight into multiple cellular functions (English)

1 reference

29 July 2017

Escher P

1

1 reference

PubMed ID

10725467

29 July 2017

Wahli W

series ordinal

2

1 reference

PubMed ID

10725467

29 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

448

1 reference

29 July 2017

2

1 reference

29 July 2017

121-138

1 reference

The nuclear receptor superfamily: the second decade

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Steroid hormone receptors: many actors in search of a plot

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Orphan nuclear receptors--new ligands and new possibilities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Nuclear receptors enhance our understanding of transcription regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

The steroid and thyroid hormone receptor superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

A unified nomenclature system for the nuclear receptor superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Ligand binding was acquired during evolution of nuclear receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Chromosomal Localisation, Inducibility, Tissue‐Specific Expression and Strain Differences in Three Murine Peroxisome‐Proliferator‐Activated‐Receptor Genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Assignment of the human nuclear hormone receptor, NUC1 (PPARD), to chromosome 6p21.1-p21.2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Structure of the mouse peroxisome proliferator activated receptor alpha gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

The organization, promoter analysis, and expression of the human PPARgamma gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Interdomain communication regulating ligand binding by PPAR-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Solution structure of the glucocorticoid receptor DNA-binding domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Solution structure of the DNA-binding domain of the oestrogen receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Structure of the retinoid X receptor alpha DNA binding domain: a helix required for homodimeric DNA binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

The RXR heterodimers and orphan receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Structural determinants of nuclear receptor assembly on DNA direct repeats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Amino acid residues in both the DNA-binding and ligand-binding domains influence transcriptional activity of the human peroxisome proliferator-activated receptor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5'-flanking region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Crystal structure of the ligand binding domain of the human nuclear receptor PPARgamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

PPAR alpha structure-function relationships derived from species-specific differences in responsiveness to hypolipidemic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Ligand-induced peroxisome proliferator-activated receptor alpha conformational change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Sequence and characterization of a coactivator for the steroid hormone receptor superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Steroid receptor coactivator-1 is a histone acetyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Role of CBP/P300 in nuclear receptor signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Nuclear receptor coactivators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

The transcriptional coactivators p300 and CBP are histone acetyltransferases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

The CBP co-activator is a histone acetyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Distinct steady-state nuclear receptor coregulator complexes exist in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Differential expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Peroxisome proliferator-activated receptor agonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Ligand selectivity of the peroxisome proliferator-activated receptor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

The PPARalpha-leukotriene B4 pathway to inflammation control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Differential activation of peroxisome proliferator-activated receptors by eicosanoids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

The ontogeny of peroxisome-proliferator-activated receptor gene expression in the mouse and rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Rat PPAR delta contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Peroxisome proliferator activated receptor-alpha expression in human liver.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

A role for fatty acids and liver fatty acid binding protein in peroxisome proliferation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Co-regulation of tissue-specific alternative human carnitine palmitoyltransferase Ibeta gene promoters by fatty acid enzyme substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: regulation by peroxisome proliferator-activated receptor gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Expression of the Peroxisome Proliferator-activated Receptor Gene Is Stimulated by Stress and Follows a Diurnal Rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

PPAR Tissue Distribution and Interactions with Other Hormone-Signaling Pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Induction of replicative DNA synthesis and PPAR alpha-dependent gene transcription by Wy-14 643 in primary rat hepatocyte and non-parenchymal cell co-cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Di(2-ethylhexyl) phthalate induces a functional zinc deficiency during pregnancy and teratogenesis that is independent of peroxisome proliferator-activated receptor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Differential activation of adipogenesis by multiple PPAR isoforms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Adipogenesis and obesity: rounding out the big picture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Troglitazone action is independent of adipose tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Thiazolidinediones and insulin resistance: peroxisome proliferatoractivated receptor gamma activation stimulates expression of the CAP gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Peroxisome proliferator-activated receptor gamma1 expression is induced during cyclic adenosine monophosphate-stimulated differentiation of alveolar type II pneumonocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Thiazolidinediones and fatty acids convert myogenic cells into adipose-like cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Terminal differentiation of human breast cancer through PPAR gamma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Peroxisome Proliferator-activated Receptor α Activation Modulates Cellular Redox Status, Represses Nuclear Factor-κB Signaling, and Reduces Inflammatory Cytokine Production in Aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Evidence for transcriptional induction of the liver fatty-acid-binding-protein gene by bezafibrate in the small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900231-6

10.1016/S0027-5107(99)00231-6

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10725467